An increased incidence of cancer in the world has led to an increase in Oncology research. Clinical research is a critical component in expanding the treatment options for people with all types of cancer. Oncology clinical trials are distinct from trials in other disease areas in their unique patient populations, treatment and toxicity monitoring, endpoint assessment and follow-up. Well designed oncology clinical trials are a key part of developing safe and effective anti-cancer drugs.
Analysis and reporting of Oncology trials is getting more complex day-by-day due to the varying mechanism of action introduced by novel anti-cancer agents, thus challenging the researchers to reconsider whether the conventional efficacy and safety analyses as well as trial designs adequately address these new mechanisms under study. Therefore, the focus of this session is to share the different intricacies of Oncology trials and how statisticians and programmers can contribute in the development of innovative cancer drugs.